Dr. Bidard on the Clinical Utility of Circulating Tumor Cell Count in Breast Cancer
December 6th 2018Francois-Clement Bidard, MD, PhD, professor, medical oncologist, Institut Curie, discusses the clinical utility of circulating tumor cell count (CTC) in breast cancer at the 2018 San Antonio Breast Cancer Symposium.
Read More